Cite

HARVARD Citation

    Abramson, J. et al. (n.d.). HIGH CR RATES IN RELAPSED/REFRACTORY (R/R) AGGRESSIVE B‐NHL TREATED WITH THE CD19‐DIRECTED CAR T CELL PRODUCT JCAR017 (TRANSCEND NHL 001). Hematological oncology. p. 138. [Online]. 
  
Back to record